Primary Site >> Liver Cancer
Gene >> ALPK2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells. PMID: 8393423 |
Ref: Expression of CD44 in human hepatocellular carcinoma cell lines. PMID: 7537711 |
Ref: Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines. PMID: 8707262 |
Ref: A new human hepatocellular carcinoma cell line (HAK-2) forms various structures in collagen gel matrices. PMID: 9436038 |
Ref: Establishment and characterization of a new human hepatocellular carcinoma cell line, HAK-3, and its response to growth factors. PMID: 10493947 |
Ref: Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. PMID: 11343236 |
Ref: Different antiviral activities of IFN-alpha subtypes in human liver cell lines: synergism between IFN-alpha2 and IFN-alpha8. PMID: 12270738 |
Ref: Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo. PMID: 15519651 |
Ref: Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo. PMID: 16953837 Ref: High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma. PMID: 16965600 Ref: Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines. PMID: 16984596 |
Ref: Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo. PMID: 17572015 Ref: Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells. PMID: 17699726 |
Ref: N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase. PMID: 21775055 |
Ref: Antiproliferative effects of sorafenib and pegylated IFNalpha2b on human liver cancer cells in vitro and in vivo. PMID: 23588838 Ref: Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity. PMID: 23648141 Ref: Pegylated interferon-alpha2a inhibits proliferation of human liver cancer cells in vitro and in vivo. PMID: 24349459 |
Ref: Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells. PMID: 24325739 |
Ref: Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma. PMID: 27329724 |
Ref: High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine. PMID: 29981246 |